Surgalign Partners with Inteneural Networks

Surgalign Holdings and Inteneural Networks Inc., a developer of artificial intelligence (AI)-based applications focused on fully autonomous central nervous system imaging analytics, began a strategic collaboration agreement. Surgalign will gain access to Inteneural’s proprietary technology for evaluation of future integration into the Surgalign digital surgery portfolio.
 
Inteneural develops and owns software that allows computers to autonomously segment and identify neural structures in medical images and rapidly deliver reference information using machine learning algorithms. These algorithms have potential for future applications in cranial and neurosurgery for referencing of tumor, aneurysm, stroke, and neurovascular structures using existing magnetic resonance imaging and computed tomography technology.
 
“While our initial focus is the application of digital surgery in spine procedures, we have a much more expansive vision for what we believe is possible with emerging technologies. New developments in the application of AI in neurosurgery and medical imaging make it an attractive space to further expand. Inteneural has developed machine learning-based analytics and fully autonomous brain anatomy segmentation capabilities that would be incredibly powerful when combined with neurosurgery,” Terry Rich, Surgalign CEO told the press. “The agreement between Surgalign and Inteneural sets the foundation for potentially enhanced research and development efficiencies, expansion of the addressable markets, and acceleration of the technological progress in the digital surgery space generally.”
 
“It’s important to note that this collaboration builds on the overwhelmingly positive feedback we have been receiving recently from spine surgeons, many of whom also specialize in neurosurgery, during demonstrations of the Holosurgical platform,” Rich added.
The agreement provides for a period during which Surgalign will evaluate the Inteneural technology on an exclusive basis, and work with Inteneural to determine the feasibility of a more comprehensive collaboration.